Ad is loading...
SCVFX
Price
$34.79
Change
-$0.30 (-0.85%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

SCVFX vs VISVX

Header iconSCVFX vs VISVX Comparison
Open Charts SCVFX vs VISVXBanner chart's image
Allspring Small Company Value C
Price$34.79
Change-$0.30 (-0.85%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
SCVFX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SCVFX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCVFX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. SCVFX (699M). VISVX pays higher dividends than SCVFX: VISVX (1.90) vs SCVFX (0.00). SCVFX was incepted earlier than VISVX: SCVFX (22 years) vs VISVX (27 years). SCVFX is a more actively managed with annual turnover of: 87.00 vs. VISVX (16.00). SCVFX has a lower initial minimum investment than VISVX: SCVFX (1000) vs VISVX (3000). SCVFX (28.76) and VISVX (28.71) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. SCVFX (46.61).
SCVFXVISVXSCVFX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years27 years-
Gain YTD13.87915.43390%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets699M57.6B1%
Annual Yield % from dividends0.001.90-
Returns for 1 year28.7628.71100%
Returns for 3 years-1.7813.23-13%
Returns for 5 years46.6157.3281%
Returns for 10 years90.49108.2184%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics